Japanese encephalitis in Hong Kong

Hong Kong Medical Journal

Volumn 11, Issue 3, 2005, Pages 182-188

  Lam, K ^a   Tsang, O T Y ^b   Yung, R W H ^b   Lau, K K ^c  

^a Caritas Medical Centre Hong Kong   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Asia, Southeastern; Encephalitis, Japanese; Epidemiology; Hong Kong

Indexed keywords

ALPHA INTERFERON A; DEXAMETHASONE; DIETHYLTOLUAMIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSECT REPELLENT; INSECTICIDE; LARVICIDAL AGENT; LIVE VACCINE; SA 14 14 2; SA 14 3;

ANAPHYLACTIC SHOCK; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEMENT FIXATION; COST EFFECTIVENESS ANALYSIS; CULEX; EDEMA; ELECTROENCEPHALOGRAPHY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; FLUORESCENT ANTIBODY TECHNIQUE; GENOTYPE; HEADACHE; HEART ARREST; HEMAGGLUTINATION INHIBITION; HONG KONG; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; INFECTION CONTROL; JAPANESE ENCEPHALITIS VIRUS; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PIG FARMING; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOUTH KOREA; SWINE DISEASE; SYMPTOMATOLOGY; VACCINATION; VECTOR CONTROL;

ENCEPHALITIS, JAPANESE; HONG KONG; HUMANS; JAPANESE ENCEPHALITIS VACCINES; VACCINATION;

EID: 20444460280     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Amendment to the Quarantine and Prevention of Disease Ordinance, Cap. 141. Centre for Health Protection website: http://www.chp.gov.hk/files/pdf/ LTD_QnP_20040714.pdf. Accessed 13 Jul 2004.
2. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000;68:405-15.
3. Miyake M. The pathology of Japanese encephalitis. A review. Bull World Health Organ 1964;30:153-60.
4. Sohn YM. Japanese encephalitis immunization in South Korea: past, present, and future. Emerg Infect Dis 2000;6:17-24.
5. Halstead SB, Tsai TF. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA. Vaccines. 4th ed. Philadelphia: WB Saunders Co; 2004:919-58.
6. Poneprasert B. Japanese encephalitis in children in northern Thailand. Southeast Asian J Trop Med Public Health 1989; 20:599-603.
7. Japanese encephalitis on the Australian mainland. Australian Government Department of Health and Ageing website: http://www.health.gov.au/internet/wcms/ Publishing.nsf/Content/cda-pubs-cdi-cdi1998.htm. Accessed 16 Mar 2005.
8. Handy R, Lang S. Flavivirus encephalitis. N Engl J Med 2004; 351:1803-4.
9. Chen WR, Tesh RB, Rico-Hese R. Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 1990;71: 2915-22.
10. Solomon T, Winter PM. Neurovirulence and host factors in flavivirus encephalitis-evidence from clinical epidemiology. Arch Virol Suppl 2004;18:161-70.
11. Huang CH. Studies of virus factors as causes of inapparent infection in Japanese B encephalitis: virus strains, viraemia, stability to heat and infective dosage. Acta Virol 1957;1:36-45.
12. Huang CH. Studies of Japanese encephalitis in China. Adv Virus Res 1982;27:71-101.
13. Solomon T. Flavivirus encephalitis. N Engl J Med 2004;351: 370-8.
14. Solomon T. Recent advances in Japanese encephalitis. J Neurovirol 2003;9:274-83.
15. Schneider RJ, Firestone MH, Edelman R, Chieowanich P, Pornpibul R. Clinical sequelae after Japanese encephalitis: a one-year follow-up study in Thailand. Southeast Asian J Trop Med Public Health 1974;5:560-8.
16. Grossman RA, Edelman R, Willhight M, Pantuwatana S, Udomsakdi S. Study of Japanese encephalitis virus in Chiangmai valley, Thailand. 3. Human seroepidemiology and inapparent infections. Am J Epidemiol 1973;98:133-49.
17. Chakraborty MS, Chakravarti SK, Mukherjee KK, Mitra AC. Inapparent infection by Japanese encephalitis (JE) virus in West Bengal. Indian J Public Health 1981;24:121-7.
18. Grossman RA, Edelman R, Chiewanich P, Voodhikul P, Siriwan C. Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. II. Human clinical infections. Am J Epidemiol 1973;98:121-32.
19. Halstead SB, Grosz CR. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am J Hyg 1962;75:190-201.
20. Solomon T, Kneen R, Dung NM, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998;351: 1094-7.
21. Dickerson RB, Newton JR, Hansen JE. Diagnosis and immediate prognosis of Japanese encephalitis; observations based on more than 200 patients with detailed analysis of 65 serologically confirmed cases. Am J Med 1952;12:277-88.
22. Misra UK, Kalita J. Movement disorders in Japanese encephalitis. J Neurol 1997;244:299-303.
23. Chaturvedi UC, Mathur A, Chandra A, Das SK, Tandon HO, Singh UK. Transplacental infection with Japanese encephalitis virus. J Infect Dis 1980;141:712-5.
24. Kumar S, Misra UK, Kalita J, Salwani V, Gupta RK, Gujral R. MR1 in Japanese encephalitis. Neuroradiology 1997;39: 180-4.
25. Misra UK, Kalita J, Jain SK, Mathur A. Radiological and neurophysiological changes in Japanese encephalitis. J Neurol Neurosurg Psychiatry 1994;57:1484-7.
26. Kimura K, Dosaka A, Hashimoto Y, Yasunaga T, Uchino M, Ando M. Single-photon emission CT findings in acute Japanese encephalitis. Am J Neuroradiol 1997;18:465-9.
27. Gajanana A, Samuel PP, Thenmozhi V, Rajendran R. An appraisal of some recent diagnosis assays for Japanese encephalitis. Southeast Asian J Trop Med Public Health 1996; 27:673-9.
28. Igarashi A, Tanaka M, Morita K, et al. Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan. Microbiol Immunol 1994;38:827-30.
29. Solomon T, Thao LT, Dung NM, et al. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay. J Clin Microbiol 1998;36:2030-4.
30. Koraka P, Zeller H, Niedrig M, Osterhaus AD, Groen J. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 2002;4:1209-15.
31. Kimura-Kuroda J, Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J Gen Virol 1986; 67:2663-72.
32. Ni H, Barrett AD. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J Gen Virol 1996;77:1449-55.
33. Harinasuta C, Nimmanitya S, Titsyakorn U. The effect of interferon-alpha A on two cases of Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 1985;16: 332-6.
34. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003;361:821-6.
35. Hoke CH Jr, Vaughn DW, Nisalak A, et al. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992;165: 631-7.
36. Japanese encephalitis: report of a World Health Organization Working Group. MMWR Morb Mortal Wkly Rep 1984;33: 119-25.
37. The Yellow Book. Health information for international travel, 2003-2004. Protection against mosquitoes and other arthropods. CDC website: http://www.cdc.gov/travel/bugs.htm. Accessed 10 Sep 2004.
38. Vaughn DW, Hoke CH Jr. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemol Rev 1992; 14:197-221.
39. Monath TP. Japanese encephalitis-plague of the Orient. N Engl J Med 1988;319:641-3.
40. Hoke CH, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988;319:608-14.
41. Plesner AM, Arlien-Soborg P, Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998;5:479-85.
42. Ruff TA, Eisen D, Fuller A, Kass R. Adverse reactions to Japanese encephalitis vaccine. Lancet 1991;338:881-2.
43. Xin YY, Ming ZG, Peng GY, Jian A, Min LH. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA 14-14-2) for children. Am J Trop Med Hyg 1988;39:214-7.
44. Vaughn DW, Hoke CH Jr. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol Rev 1992; 14:197-221.
45. Two recent cases of Japanese encephalitis in Hong Kong. Centre for Health Protection website: http://www.chp.gov.hk/files/pdf7grp-CDW_V1_1-en-20040630. pdf. Accessed 10 Sep 2004.
46. Fu A. A seroprevalence study of Japanese encephalitis in Hong Kong 2004. Centre for Health Protection website: http://www. chp.gov.hk/files/pdf/grp- CDW_V1_04-en-2004081100.pdf. Accessed 10 Sep 2004.
47. Self LS, Ree HI, Lofgren CS, et al. Aerial applications of ultra-low-volume insecticides to control the vector of Japanese encephalitis in Korea. Bull World Health Organ 1973;49:353-7.
48. Benenson MW, Top FH Jr, Gresso W, Ames CW, Altstatt LB. The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 1975;24:974-80.
49. Chunsuttiwat S. Japanese encephalitis in Thailand. Southeast Asian J Trop Med Public Health 1989;20:593-7.
50. Solomon T. Vaccines against Japanese encephalitis. In: Jong EC, Zuckerman JN, editors. Travelers' vaccines. Ontario, Canada: BC Decker; 2004:219-56.
51. Wada Y. Control of Japanese encephalitis vectors. Southeast Asian J Trop Med Public Health 1989;20:623-6.
52. Yuen C. Hong Kong livestock and products, semi-annual 2005. USDA Foreign Agricultural Service. Global Agriculture Information Network (GAIN) Report. 2005:8-13. The Pigsite website: http://www.thepigsite.com/frame.asp?link=http:// www.fas.usda.gov/gainfiles/200502/146118634.pdf. Accessed 31 Jan 2005.
53. Chung PH, Lam R. Epidemiology of Japanese encephalitis in Hong Kong, 1967-2003. Public Health and Epidemiology Bulletin 2004;13:17-21.